0

Cardiology Collection
 341-360 of 5013 Articles
Articles |  21 April 2009 FREE
Differences in Control of Cardiovascular Disease and Diabetes by Race, Ethnicity, and Education: U.S. Trends From 1999 to 2006 and Effects of Medicare Coverage
J. Michael McWilliams, MD, PhD; Ellen Meara, PhD; Alan M. Zaslavsky, PhD; et al.
Ann Intern Med. 2009;150(8):505-515. doi:10.7326/0003-4819-150-8-200904210-00005
Editorials |  7 April 2009
The Future of Tobacco Treatment in the Health Care System
Nancy A. Rigotti, MD
Ann Intern Med. 2009;150(7):496-497. doi:10.7326/0003-4819-150-7-200904070-00011
Reviews |  7 April 2009
Systematic Review: Association of Low-Density Lipoprotein Subfractions With Cardiovascular Outcomes
Stanley Ip, MD; Alice H. Lichtenstein, ScD; Mei Chung, MPH; et al.
Ann Intern Med. 2009;150(7):474-484. doi:10.7326/0003-4819-150-7-200904070-00007
Articles |  7 April 2009
Triple-Combination Pharmacotherapy for Medically Ill Smokers: A Randomized Trial
Michael B. Steinberg, MD, MPH; Shelley Greenhaus, RN, MPH; Amy C. Schmelzer, MS; et al.
Ann Intern Med. 2009;150(7):447-454. doi:10.7326/0003-4819-150-7-200904070-00004
Articles |  7 April 2009
Effect of Varying Levels of Disease Management on Smoking Cessation: A Randomized Trial
Edward F. Ellerbeck, MD, MPH; Jonathan D. Mahnken, PhD; A. Paula Cupertino, PhD; et al.
Ann Intern Med. 2009;150(7):437-446. doi:10.7326/0003-4819-150-7-200904070-00003
Editorials |  17 March 2009 FREE
First Do No Harm … Reduction?
Marc N. Gourevitch, MD, MPH
Ann Intern Med. 2009;150(6):417-418. doi:10.7326/0003-4819-150-6-200903170-00111
Editorials |  17 March 2009
Aspirin for Prevention and Treatment of Cardiovascular Disease
Shamir R. Mehta, MD, MSc
Ann Intern Med. 2009;150(6):414-416. doi:10.7326/0003-4819-150-6-200903170-00011
Articles |  17 March 2009
Aspirin to Prevent Cardiovascular Disease: The Association of Aspirin Dose and Clopidogrel With Thrombosis and Bleeding
Steven R. Steinhubl, MD; Deepak L. Bhatt, MD, MPH; Danielle M. Brennan, MS; et al.
Ann Intern Med. 2009;150(6):379-386. doi:10.7326/0003-4819-150-6-200903170-00006
Articles |  3 March 2009
Factors Associated With Racial Differences in Myocardial Infarction Outcomes
John A. Spertus, MD, MPH; Philip G. Jones, MS; Frederick A. Masoudi, MD, MSPH; et al.
Ann Intern Med. 2009;150(5):314-324. doi:10.7326/0003-4819-150-5-200903030-00007
Articles |  3 March 2009
Response to Newly Prescribed Lipid-Lowering Therapy in Patients With and Without HIV Infection
Michael J. Silverberg, PhD, MPH; Wendy Leyden, MPH; Leo Hurley, MPH; et al.
Ann Intern Med. 2009;150(5):301-313. doi:10.7326/0003-4819-150-5-200903030-00006
Articles |  17 February 2009
Comparing Impact and Cost-Effectiveness of Primary Prevention Strategies for Lipid-Lowering
Mark J. Pletcher, MD, MPH; Lawrence Lazar, MD; Kirsten Bibbins-Domingo, PhD, MD; et al.
Ann Intern Med. 2009;150(4):243-254. doi:10.7326/0003-4819-150-4-200902170-00005
Academia and the Profession |  3 February 2009 FREE
STrengthening the REporting of Genetic Association Studies (STREGA): An Extension of the STROBE Statement
Julian Little, PhD; Julian P.T. Higgins, PhD; John P.A. Ioannidis, MD, PhD; et al.
Ann Intern Med. 2009;150(3):206-215. doi:10.7326/0003-4819-150-3-200902030-00011
Articles |  3 February 2009
Contrast Volume During Primary Percutaneous Coronary Intervention and Subsequent Contrast-Induced Nephropathy and Mortality
Giancarlo Marenzi, MD; Emilio Assanelli, MD; Jeness Campodonico, MD; et al.
Ann Intern Med. 2009;150(3):170-177. doi:10.7326/0003-4819-150-3-200902030-00006
Editorials |  20 January 2009
Personalized Genetic Prediction: Too Limited, Too Expensive, or Too Soon?
John P.A. Ioannidis, MD
Ann Intern Med. 2009;150(2):139-141. doi:10.7326/0003-4819-150-2-200901200-00012
Reviews |  20 January 2009
Narrative Review: Effect of Bariatric Surgery on Type 2 Diabetes Mellitus
Marion L. Vetter, MD, RD; Serena Cardillo, MD; Michael R. Rickels, MD, MS; et al.
Ann Intern Med. 2009;150(2):94-103. doi:10.7326/0003-4819-150-2-200901200-00007
Articles |  20 January 2009
High-Density Lipoprotein Particle Size and Concentration and Coronary Risk
Karim El Harchaoui, MD; Benoit J. Arsenault, MSc; Remco Franssen, MD; et al.
Ann Intern Med. 2009;150(2):84-93. doi:10.7326/0003-4819-150-2-200901200-00006
Articles |  20 January 2009
Cost-Effectiveness of Using Pharmacogenetic Information in Warfarin Dosing for Patients With Nonvalvular Atrial Fibrillation
Mark H. Eckman, MD, MS; Jonathan Rosand, MD, MSc; Steven M. Greenberg, MD, PhD; et al.
Ann Intern Med. 2009;150(2):73-83. doi:10.7326/0003-4819-150-2-200901200-00005
Articles |  20 January 2009 FREE
Cardiovascular Disease Risk Prediction With and Without Knowledge of Genetic Variation at Chromosome 9p21.3
Nina P. Paynter, PhD; Daniel I. Chasman, PhD; Julie E. Buring, ScD; et al.
Ann Intern Med. 2009;150(2):65-72. doi:10.7326/0003-4819-150-2-200901200-00003
Articles |  6 January 2009
Association Between Statin Use and Risk for Keratinocyte Carcinoma in the Veterans Affairs Topical Tretinoin Chemoprevention Trial
David D. Dore, PharmD, PhD; Kate L. Lapane, PhD; Amal N. Trivedi, MD, MPH; et al.
Ann Intern Med. 2009;150(1):9-18. doi:10.7326/0003-4819-150-1-200901060-00004
Articles |  2 December 2008
Sex Differences in Morphology and Outcomes of Mitral Valve Prolapse
Jean-François Avierinos, MD; Jocelyn Inamo, MD; Francesco Grigioni, MD; et al.
Ann Intern Med. 2008;149(11):787-794. doi:10.7326/0003-4819-149-11-200812020-00003
Advertisement
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)